PPTDF (PeptiDream) Payments of Debt: $-121.0 Mil (TTM As of Mar. 2026)


PPTDF PeptiDream Inc PPTDF
72 GF Score
Price $6.00
GF Value $10.26
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PeptiDream Payments of Debt?

PeptiDream PPTDF 72 Payments of Debt is $-121.0 Mil as of Mar. 2026. GuruFocus rates PPTDF with a GF Score™ of 72/100 and a GF Value™ of $10.26 (Possible Value Trap). The stock has 4 warning signs investors should review.

PeptiDream's Payments of Debt for the three months ended in Mar. 2026 was $-107.8 Mil.

PeptiDream's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was $-121.0 Mil.

PeptiDream Payments of Debt Related Terms

PeptiDream Payments of Debt Historical Data

* Premium members only.

The historical data trend for PeptiDream's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PeptiDream Payments of Debt Chart

PeptiDream Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -12.45 -19.72 -17.16 -16.93

PeptiDream Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.43 -4.57 -4.46 -4.23 -107.76
PPTDF
72GF Score
PeptiDream Inc PPTDF
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PeptiDream Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-121.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-121.0 Mil mean?
PeptiDream (PPTDF) has a Payments of Debt of $-121.0 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on PeptiDream and its competitors.
Is PeptiDream's Payments of Debt too high?
PeptiDream's current Payments of Debt is $-121.0 Mil. Overall, PeptiDream has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PeptiDream's Payments of Debt compare to VRTX and REGN?
PeptiDream's Payments of Debt of $-121.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on PeptiDream and its competitors. PeptiDream's current Payments of Debt is $-121.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PeptiDream stock overvalued right now?
Based on GuruFocus' analysis, PeptiDream (PPTDF) is currently considered Possible Value Trap. The stock's GF Value™ is $10.26, compared to a current price of $6.00 — trading 41.5% below its estimated fair value. The current Payments of Debt is $-121.0 Mil. PeptiDream's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For PeptiDream (PPTDF), the current Payments of Debt is $-121.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PeptiDream (PPTDF) Overvalued in 2026?

Based on GuruFocus' analysis, PeptiDream stock appears to be undervalued. The current stock price of $6.00 is trading 41.5% below its estimated GF Value™ of $10.26. GuruFocus considers PeptiDream to be Possible Value Trap.

Key valuation signals for PPTDF:

  • Payments of Debt: $-121.0 Mil
  • GF Value™: $10.26 vs. price of $6.00 (41.5% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the PPTDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PeptiDream Business Description

Other Exchanges 4587:Japan
Address 3-25-23 Tonomachi, Kawasaki-ku, Kanagawa Prefecture, Kawasaki, JPN, 210-0821
PeptiDream Inc is engaged in the drug discovery and development business. The group utilizes PDPS, its proprietary drug discovery and development platform system, for drug discovery and development, and it conducts radiopharmaceutical business through a wholly owned subsidiary and is involved in the research, development, and manufacturing of pharmaceuticals, etc. Its reportable segments are Drug discovery and development business and Radiopharmaceutical business.
72GF Score

Get the complete analysis for PPTDF

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.00
Price
$10.26
GF Value